8.
Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One. 2012;7(12), e52787. doi:10.1371/journal.pone.0052787. Epub 2012 Dec 27.PubMedCentralCrossRefPubMed
9.
Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014;14(4):535–48. doi:10.1016/j.stem.2014.01.CrossRefPubMed
10.
11.
Hemmi N, Tohyama S, Nakajima K, Kanazawa H, Suzuki T, Hattori F, et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cells Transl Med. 2014;3(12):1473–83. doi:10.5966/sctm.2014-0072. Epub 2014 Oct 29.CrossRefPubMed
12.
Hayashi R, Ishikawa Y, Ito M, Kageyama T, Takashiba K, Fujioka T, et al. Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One. 2012;7(9), e45435. doi:10.1371/journal.pone.0045435. Epub 2012 Sep 24.PubMedCentralCrossRefPubMed